Immunohistochemical investigation of α1 (IV) and α5 (IV) collagen chains in a broad spectrum of melanocytic tumours

Melanoma Research

Volumn 15, Issue 3, 2005, Pages 161-168

  Quatresooz, Pascale ^a,b   Piérard, Gérald E ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b CHU SART TILMAN   (Belgium)

Author keywords

Basement membrane; Collagen IV; Malignant melanoma; Melanocyte; Naevus

Indexed keywords

COLLAGEN ANTIBODY; COLLAGEN TYPE 4; COLLAGEN TYPE 4 ALPHA1 CHAIN; COLLAGEN TYPE 4 ALPHA3 CHAIN; COLLAGEN TYPE 4 ALPHA5 CHAIN; UNCLASSIFIED DRUG; COL4A5 PROTEIN, HUMAN;

ARTICLE; BASEMENT MEMBRANE; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL MIGRATION; CYTOPLASM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; JUVENILE MELANOMA; MELANOCYTIC NEVUS; MELANOCYTOSIS; MELANOMA; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; CELL COMMUNICATION; CHEMISTRY; COMPARATIVE STUDY; PATHOLOGY; PIGMENTED NEVUS; SKIN TUMOR; TISSUE FIXATION;

CELL COMMUNICATION; COLLAGEN TYPE IV; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; NEVUS, PIGMENTED; SKIN NEOPLASMS; TISSUE FIXATION;

EID: 20544455553     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200506000-00004     Document Type: Article

References (51)

1. Bosetti C, La Vecchia C, Naldi L, Lucchini F, Negri E, Levi F. Mortality from cutaneous malignant melanoma in Europe. Has the epidemic levelled off? Melanoma Res 2004; 14:301-309.
2. Quatresooz P, Uhoda I, Fumal I, Piérard-Franchimont C, Piérard GE. Revisiting the gender-linked melanoma burden. Dermatology 2004; 209:197-201.
3. Uhoda I, Quatresooz P, Fumal I, Nikkels AF, Piérard-Franchimont C, Piérard GE. Updating trends in cutaneous cancers in south-east Belgium. Oncol Reports 2004; 12:111-114.
4. Quatresooz P, Arrese JE, Piérard-Franchimont C, Piérard GE. Immunohistochemical aid at risk stratification of melanocytic neoplasms. Int J Oncol 2004; 24:211-216.
5. Claessens N, Arrese JE, Piérard-Franchimont C, Piérard GE, Quatresooz P. Immunohistochemical detection of incipient melanoma micrometastasis. Relationship with sentinel lymph node involvement. Melanoma Res 2005; 15:107-110.
6. Ghohestani RF, Li K, Rousselle P, Uitto J. Molecular organization of the cutaneous basement membrane zone. Clin Dermatol 2001; 19:551-562.
7. Havenith MG, Ahrends JW, Simon R, Volovics A, Wiggers T, Bosman FT. Type IV collagen immunoreactivity in colorectal cancer. Prognostic value of basement membrane deposition. Cancer 1988; 62:2207-2211.
8. Damjnov I. Heterogeneity of basement membranes in normal and pathologically altered tissue. Virchow's Archiv A Pathol Anat 1990; 416:185-188.
9. Schapers RMM, Pauwels RPE, Havenith MG, Smeets AWGB, Van den Brandt PA, Bosman FT. Prognostic significance of type IV collagen and laminin immunoreactivity in urothelial carcinomas of the bladder. Cancer 1990; 66:2583-2588.
10. Schaumburg-Lever G, Lever I, Fehrenbacher B, Möller H, Bischof B, Kaiserling E, et al. Melanocytes in naevi and melanomas synthesize basement membrane and basement membrane-like material. An immunohistochemical and electron microscopic study including immunoelectron microscopy. J Cutan Pathol 2000; 27:67-75.
11. Dobashi M, Fujisawa M, Naito I, Yamazaki T, Okada H, Kamidono S. Distribution of type IV collagen subtypes in human testes and their association with spermatogenesis. Fertil Steril 2003; 80:755-760.
12. Tunggal L, Ravaux J, Pesch M, Smola H, Krieg T, Gaill F, et al. Defective laminin 5 processing in cylindroma cells. Am J Pathol 2002; 160:459-468.
13. Quatresooz P, Martalo O, Piérard GE. Differential expression of α1 (IV) and α5 (IV) collagen chains in basal cell carcinoma. J Cutan Pathol 2003; 30:548-552.
14. Forster SJ, Talbot IC, Clayton DG, Critchley DR. Tumor basement membrane laminin in adenocarcinoma of rectum: an immunohistochemical study of biological and clinical significance. Int J Cancer 1986; 33:813-817.
15. Daneker GW, Mercurio AM, Guerra L, Wolff B. Laminin expression in colorectal carcinomas varying in degree of differentiation. Arch Surg 1987; 122:1470-1474.
16. Bonkhoff H, Wernert N, Dhom G, Remberger K. Basement membranes in fetal, adult normal, hyperplastic and neoplastic human prostate. Virchow's Archiv A Pathol Anat 1991; 418:375-381.
17. Bonkhoff H, Wernert N, Dhom G, Remberger K. Distribution of basement membranes in primary and metastatic carcinomas of the prostate. Hum Pathol 1992; 23:934-939.
18. David L, Nesland JM, Holm R, Sobrinho-Simoes M. Expression of laminin, collagen IV, fibronectin, and type IV collagenase in gastric carcinoma. An immunohistochemical study of 87 patients. Cancer 1994; 73:518-527.
19. Knox JD, Cress AE, Clark V, Manriquez L, Affinito KS, Dalkin BL, et al. Differential expression of extracellular matrix molecules and the α6-integrins in the normal and neoplastic prostate. Am J Pathol 1994; 145:167-174.
20. Van Duinen CM, Fleuren GJ, Bruijn JA. The extracellular matrix in pigmented skin lesions: an immunohistochemical study. Histopathology 1994; 24:33-40.
21. Stenbäck F, Wasenius VM. Occurrence of basement membranes in pigment cell tumors of the skin, relation to cell type and clinical behavior. J Cutan Pathol 1986; 13:175-186.
22. Yaar M, Woodley DT, Gilchrest BA. Human nevocellular nevus cells are surrounded by basement membrane components. Immunohistologic studies of human nevus cells and melanocytes in vivo and in vitro. Lab Invest 1988; 58:157-162.
23. MacKie RM, Clelland DB, Skerrow CJ. Type IV collagen and laminin staining patterns in benign and malignant cutaneous lesions. J Clin Pathol 1989; 42:1173-1177.
24. Schmoekel C, Stolz W, Sakai LY, Bungeson RE, Timpl R, Krieg T. Structure of basement membranes in malignant melanoma and nevocytic naevi. J Invest Dermatol 1989; 92:663-668.
25. Lugassy C, Christensen L, Le Charpentier M, Faure E, Escande JP. Ultrastructural and immunohistochemical observations concerning laminin in B16 melanoma. Is an amorphous form of laminin promoting a non hematogenous migration of tumor cells? J Submicrosc Cytol Pathol 1998; 30:137-144.
26. Lugassy C, Dickersin GR, Christensen L, Karaoli T, LeCharpentier M, Escande JP, Barnhill RL. Ultrastructural and immunohistochemical studies of the periendothelial matrix in malignant melanoma: evidence for an amorphous matrix containing laminin. J Cutan Pathol 1999; 26:78-83.
27. Lugassy C, Eyden BP, Christensen L, Escande JP. Angio-tumoral complex in human malignant melanoma characterised by free laminin: ultrastructural and immunohistochemical observations. J Submicrosc Cytol Pathol 1997; 29:19-28.
28. Lugassy C, Shahsafaei A, Bonitz P, Busam KJ, Barnhill RL. Tumor microvessels in melanoma express the beta-2 chain of laminin. Implications for melanoma metastasis. J Cutan Pathol 1999; 26:222-226.
29. Natali PG, Nicotra MR, Bellocci M, Cavaliere R, Bigotti A. Distribution of laminin and collagen type IV in benign and malignant lesions of melanocytic origin. Int J Cancer 1985; 35:461-467.
30. Havenith MG, Van Zandvoort EHM, Cleutjens JPM, Bosman FT. Basement membrane deposition in benign and malignant naevo-melanocytic lesions: an immunohistochemical study with antibodies to type IV collagen and laminin. Histopathology 1989; 15:136-146.
31. Quatresooz P, Piérard GE. Distinct expression patterns of α1 (IV) and α5 (IV) collagen chains in cylindroma and malignant cylindroma. Int J Molec Med 2005; 15:27-31.
32. Hostikka SL, Eddy RL, Byers MG, Hoyhtya M, Shows TB, Tryggvason K. Identification of a distinct type IV collagen alpha chain with restricted kidney distribution and assignment of its gene to the locus of X chromosome-linked Alport syndrome. Proc Natl Acad Sci USA 1990; 87:1606-1610.
33. Yoshioka K, Hino S, Takemura T, Maki S, Wieslander J, Takekoshi Y, et al. Type IV collagen alpha 5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody. Am J Pathol 1994; 144:986-996.
34. Peissel B, Geng L, Kalluri R, Kashtan C, Rennke HG, Gallo GR, et al. Comparative distribution of the alpha 1 (IV), alpha 5 (IV), and alpha 6 (IV) collagen chains in normal human adult and fetal tissues and in kidneys from X-linked Alport syndrome patients. J Clin Invest 1995; 96:1948-1957.
35. Lemmink HH, Schroder CH, Monnens LA, Smeets HJ. The clinical spectrum of type IV collagen mutations. Hum Mutat 1997; 9:477-499.
36. Van der Loop FT, Monnens LA, Schroder CH, Lemmink HH, Breuning MH, Timmer ED, Smeets HJ. Identification of COL4A5 defects in Alport's syndrome by immunohistochemistry of skin. Kidney Int 1999; 55:1217-1224.
37. Delanaye P, Nikkels AF, Martalo O, Dechenne C, Arrese JE, Rorive G, Piérard GE. How to investigate Alport's syndrome by a skin biopsy. When skin speaks for kidney. Rev Med Liège 2002; 57:670-671.
38. Ainsworth AM, Folberg R, Reed RJ, Clark WH. Melanocytic naevi, melanocytomas, melanocytic dysplasias: uncommon forms of melanoma. In: Clark WH, Goldman KI, Mastrangelo MJ (editors): Human malignant melanoma - Clinical oncology monographs. New York: Grune and Stratton; 1979, pp. 167-208.
39. Smolle J, Hofmann-Wellenhof R, Fink-Puches R. Melanoma and stroma: an interaction of biological and prognostic importance. Semin Cutan Med Surg 1996; 15:326-335.
40. Yamanishi Y, Maeyens E, Dabbous MKh, Ohyama H, Hahsimoto K. Collagenolytic activity in malignant melanoma: physiochemical studies. Cancer Res 1973; 33:2507-2512.
41. Schmoeckel C, Stolz W, Burgeson R, Krieg T. Identification of basement membrane components in eosinophilic globules in a case of Spitz's nevus. Am J Dermatopathol 1990; 12:272-274.
42. Skelton HG, Miller ML, Lupton GP, Smith KJ. Eosinophilic globules in spindle cell and epithelioid cell naevi. Composition and possible origin. Am J Dermatopathol 1998; 20:547-550.
43. Murer K, Urosevic M, Willers J, Selvam P, Laine E, Burg G, Dummer R. Expression of Melan-A/MART-1 in primary melanoma cell cultures has prognostic implication in metastatic melanoma patients. Melanoma Res 2004; 14:257-262.
44. Pacifico MD, Graver R, Richman P, Daley F, Wilson GD. Validation of tissue microarray for the immunohistochemical profiling of melanoma. Melanoma Res 2004; 14:39-42.
45. Liotta LA, Rao CN, Wewer UM. Biochemical interactions of tumor cells with the basement membrane. Annu Rev Biochem 1986; 55:1037-1057.
46. Edward M, Mackie RM. Cell-cell and cell-extracellular matrix interactions during melanoma cell invasion and metastasis. Melanoma Res 1993; 3:227-234.
47. Piérard-Franchimont C, Arrese JE, Nikkels AF, Al-Saleh W, Delvenne P, Piérard GE. Factor XIIIa-positive dermal dendrocytes and proliferative activity of cutaneous cancers. Virchows Archiv 1996; 429:43-48.
48. Vacca A, Ribatti D, Roncali L, Lospalluti M, Serio G, Carrel S, et al. Melanocyte tumor progression in association with changes in angiogenesis and expression of the 67-kilodalton laminin receptor. Cancer 1993; 72:455-461.
49. Sternberg J, Kimber SJ. Distribution of fibronectin, laminin, and entactin in the environment of migrating neural crest cells in early mouse embryo. J Embryol Exp Morphol 1986; 91:267-282.
50. Sternberg J, Kimber SJ. The relationship between emerging neural crest cells and basement membranes in the trunk of the mouse embryo: a transmission electron microscopic and immunocytochemical study. J Embryol Exp Morphol 1986; 98:251-268.
51. Perris R, Paulsson M, Bronner-Fraser M. Molecular mechanisms of avian neural crest cell migration on fibronectin and laminin. Dev Biol 1989; 136:222-238.